SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001140361-21-012843
Filing Date
2021-04-15
Accepted
2021-04-15 06:03:57
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFC14A nt10022735x7_defc14a.htm DEFC14A 1015337
2 logo_adverumx1.jpg GRAPHIC 53652
3 nt10022735x7_barchart1.jpg GRAPHIC 111785
4 nt10022735x7_pc01.jpg GRAPHIC 783356
5 nt10022735x7_pc02.jpg GRAPHIC 839365
6 nt10022735x7_piechart1.jpg GRAPHIC 81771
7 nt10022735x7_piechart2.jpg GRAPHIC 76526
8 nt10022735x7_piechart3.jpg GRAPHIC 36691
  Complete submission text file 0001140361-21-012843.txt   3746794
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filed by) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-36579 | Film No.: 21827184
SIC: 2836 Biological Products, (No Diagnostic Substances)